The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Zepatier (elbasvir and grazoprevir)

What is Zepatier?

zepatierOn January 28, 2016 the U.S. Food and Drug Administration approved the prescription medication Zepatierâ„¢ (elbasvir and grazoprevir). Elbasvir is a hepatitis C virus (HCV) NS5A inhibitor while grazoprevir is an HCVNS3/4A protease inhibitor. This combination is indicated with or without ribavirin for the treatment of HCV in adult patients with genotype 1 or 4 infections.

The active ingredients of Zepatier are 50 mg elbasvir and 100 mg grazoprevir.

Last Updated: February 2016

"Highlights of Prescribing Information." Merck.com. Merck Sharp & Dohme Corp., . Retrieved February 1, 2016.

"Patient Information: Zepatierâ„¢." Merck.com. Merck Sharp & Dohme Corp., http://www.merck.com/product/usa/pi_circulars/z/zepatier/zepatier_ppi.pdf. Retrieved February 1, 2016.

"Zepatier Multiuse Savings Coupon." Activatethecard.com. Merck Sharp & Dohme Corp., https://www.activatethecard.com/7208/#. Retrieved February 1, 2016.

"Zepatier (Elbasvir and Grazoprevir) Offical Website." Zepatier.com. Merck Sharp & Dohme Corp., https://www.zepatier.com/. Retrieved February 1, 2016.